Total Payments
$1,819
2024 Payments
$722.40
Companies
12
Transactions
20
Medicare Patients
738
Medicare Billing
$127,885
Payment Breakdown by Category
Food & Beverage$1,726 (94.9%)
Education$92.99 (5.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,726 | 19 | 94.9% |
| Education | $92.99 | 1 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $361.33 | 3 | $0 (2024) |
| Vifor Pharma, Inc. | $325.09 | 3 | $0 (2024) |
| Relypsa, Inc. | $242.35 | 2 | $0 (2019) |
| CALLIDITAS THERAPEUTICS US INC. | $207.89 | 2 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $112.64 | 1 | $0 (2019) |
| Outset Medical Inc | $100.12 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $99.87 | 1 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $92.99 | 1 | $0 (2021) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $91.74 | 1 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $84.37 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $722.40 | 8 | Vifor Pharma, Inc. ($325.09) |
| 2023 | $168.39 | 3 | Bayer Healthcare Pharmaceuticals Inc. ($84.37) |
| 2022 | $38.66 | 1 | Aurinia Pharma U.S., Inc. ($38.66) |
| 2021 | $192.86 | 2 | AstraZeneca Pharmaceuticals LP ($99.87) |
| 2019 | $696.73 | 6 | Alexion Pharmaceuticals, Inc. ($250.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $123.87 | General |
| Category: Nephrology | ||||||
| 10/26/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $61.99 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $112.23 | General |
| Category: Hyperkalemia | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $111.33 | General |
| 07/11/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $116.26 | General |
| Category: Hyperkalemia | ||||||
| 04/24/2024 | Outset Medical Inc | — | Food and Beverage | In-kind items and services | $65.34 | General |
| 04/24/2024 | Outset Medical Inc | — | Food and Beverage | In-kind items and services | $34.78 | General |
| 01/11/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $96.60 | General |
| Category: Hyperkalemia | ||||||
| 11/15/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $84.02 | General |
| Category: Nephrology | ||||||
| 11/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $59.37 | General |
| Category: Cardio-renal | ||||||
| 10/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardio-renal | ||||||
| 02/08/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $38.66 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/16/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $99.87 | General |
| 06/21/2021 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $92.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $120.33 | General |
| Category: Hyperkalemia | ||||||
| 10/09/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/03/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $91.74 | General |
| 06/11/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 05/10/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $122.02 | General |
| Category: Hyperkalemia | ||||||
| 01/22/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $112.64 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 230 | 581 | $175,010 | $49,266 |
| 2022 | 5 | 167 | 272 | $70,989 | $22,266 |
| 2021 | 8 | 287 | 521 | $130,509 | $45,106 |
| 2020 | 3 | 54 | 127 | $34,640 | $11,247 |
Total Patients
738
Total Services
1,501
Medicare Billing
$127,885
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 74 | 284 | $80,940 | $26,501 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 104 | 231 | $69,993 | $15,651 | 22.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 41 | $19,352 | $5,573 | 28.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 25 | $4,725 | $1,541 | 32.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 48 | 94 | $23,599 | $7,684 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 54 | 92 | $21,680 | $6,448 | 29.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 32 | 35 | $16,926 | $5,335 | 31.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 40 | $6,840 | $2,379 | 34.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 11 | 11 | $1,944 | $421.06 | 21.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 80 | 213 | $54,741 | $19,142 | 35.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 71 | 115 | $22,195 | $8,832 | 39.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 40 | 43 | $21,543 | $7,108 | 33.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 40 | 61 | $10,858 | $3,575 | 32.9% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 12 | 39 | $9,867 | $2,642 | 26.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 17 | 17 | $4,658 | $1,971 | 42.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 16 | 20 | $4,320 | $1,118 | 25.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 11 | 13 | $2,327 | $718.08 | 30.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 26 | 91 | $23,387 | $7,560 | 32.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 15 | $7,515 | $2,461 | 32.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 21 | $3,738 | $1,225 | 32.8% |
About Niralee Patel
Niralee Patel is a Nephrology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1053721654.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Niralee Patel has received a total of $1,819 in payments from pharmaceutical and medical device companies, with $722.40 received in 2024. These payments were reported across 20 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,726).
As a Medicare-enrolled provider, Patel has provided services to 738 Medicare beneficiaries, totaling 1,501 services with total Medicare billing of $127,885. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Cincinnati, OH
- Active Since 05/05/2014
- Last Updated 05/05/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1053721654
Products in Payments
- Veltassa (Drug) $567.44
- TARPEYO (Drug) $207.89
- ACTHAR (Biological) $205.63
- Kerendia (Drug) $84.37
- TAVNEOS (Drug) $61.99
- LUPKYNIS (Drug) $38.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Cincinnati
Francisco Flores, M.d, M.D
Nephrology — Payments: $163,331
Nephrology $163,331
Dr. Tahir Sajjad, M.d, M.D
Nephrology — Payments: $37,686
Nephrology $37,686
Dr. Arshdeep Tindni, M.d, M.D
Nephrology — Payments: $31,882
Nephrology $31,882
Dr. Joseph Kremer, M.d, M.D
Nephrology — Payments: $29,341
Nephrology $29,341
Dr. Karl Pembaur, M.d, M.D
Nephrology — Payments: $7,169
Nephrology $7,169
Dr. Ajay Srivastava, Md, MD
Nephrology — Payments: $6,069
Nephrology $6,069